Brochure

Obesity & Metabolic Disease Imaging Capabilities

Navigate the growing complexity of obesity and metabolic disease clinical trials with an imaging partner backed by over 30 years of clinical imaging experience. Voiant combines specialized clinical and operational expertise, advanced multimodality image analysis including MRI and DXA, and strategic technology partnerships to deliver quantitative imaging biomarkers that go beyond BMI, revealing fat distribution, muscle preservation, and organ-level metabolic changes. These insights provide a deeper understanding treatment response across obesity, MASLD/MASH, diabetes, and other cardiometabolic diseases for sponsors.

Obesity & Metabolic Disease Imaging Capabilities

What's inside:

Body Composition & Metabolic Imaging Expertise
In-house DXA subject matter experts, hands-on site support, and coordinated expert oversight delivering consistent and high-quality body composition assessments
Expansive Metabolic Imaging Biomarkers
Quantitative imaging biomarkers, including visceral adipose tissue, muscle fat infiltration, and liver fat quantification (PDFF) that help characterize treatment response beyond the scale
Voiant Hub 2.0, ReadReady™, and Seamless Partner Integrations
AI-powered image quality control and advanced body composition analytics that help deliver high-quality imaging endpoints with deeper insights into the quality of weight loss

Fill out the form below to download now:

"*" indicates required fields

Name*
Webinars, white papers, product news, and clinical trial insights - unsubscribe anytime.
Webinars, white papers, product news, and clinical trial insights - unsubscribe anytime.